Kangji Medical Holdings Limited

HKEX:9997.HK

5.98 (HKD) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22018 Q12017 Q42017 Q22017 Q12016 Q4
Operating Activities:
Net Income 285.847248.56255.461321.022157.713257.431199.358169.55480.742122.82683.61851.61136.67536.67536.67529.42629.42629.426
Depreciation & Amortization 14.17916.79216.16212.6378.9396.2925.494.3963.7753.6353.1761.7111.5651.5651.5651.6181.6181.618
Deferred Income Tax 007.72752.12854.72415.249-12.2745.147.162000000000
Stock Based Compensation 6.1831.357.2733.447.5265.1223.1632.40815.593000000000
Change In Working Capital -1.349-26.77-32.395-55.558-90.575-6.81623.177-19.532-12.98118.557-32.46-2.869-4.59-4.59-4.59-0.491-0.491-0.491
Accounts Receivables 19.701-66.573-7.651-46.112-34.86-7.76113.4352.881-18.6648.992-34.7960000000
Change In Inventory -15.1767.543-7.349-9.456-27.39-12.61-4.324-10.429-4.0910.499-0.2620.059-2.729-2.729-2.729-2.115-2.115-2.115
Change In Accounts Payables 000000000000000000
Other Working Capital -5.87432.26-17.3950.01-28.32513.55514.066-11.9849.7749.0662.598-2.929-1.861-1.861-1.8611.6241.6241.624
Other Non Cash Items -83.13810.133-76.951-90.97945.148-58.9491.481-15.37-7.54176.23750.25331.00817.53417.53417.5345.1255.1255.125
Operating Cash Flow 221.722250.065169.55190.562128.751203.08232.669141.45679.588221.255104.58781.46151.18451.18451.18435.67935.67935.679
Investing Activities:
Investments In Property Plant And Equipment -35.3-63.202-23.619-45.25-30.447-19.039-11.826-9.044-8.789-2.455-7.108-2.391-3.875-3.875-3.875-3.098-3.098-3.098
Acquisitions Net 0000-19.8230000000000000
Purchases Of Investments 00000000000-278.285-113.025-113.025-113.025000
Sales Maturities Of Investments 00000000000275.592108.251108.251108.251000
Other Investing Activites 1,248.664921.405-1,226.2827.128-301.591638.26-767.488-718.791125.646269.565-76.8675.0848.6498.6498.6493.0983.0983.098
Investing Cash Flow 1,213.364858.203-1,249.899-18.122-351.861619.221-779.314-727.835116.857267.11-83.97542.797-65.047-65.047-65.047-10.224-10.224-10.224
Financing Activities:
Debt Repayment -4.8870-4.7180-5.4540-0.819000-0.0030000000
Common Stock Issued 000000000000000000
Common Stock Repurchased -30.805-2.873-13.707-268.702-13.062-51.07400-402.29000000000
Dividends Paid 0-216.3490-179.9470-0.001-44.846-23.635-188.92800-26.568000000
Other Financing Activities 0-4.708-1.177-4.912-0.715-0.870-34.6012,801.265-106.29026.568000000
Financing Cash Flow -35.692-223.93-19.602-453.561-19.231-51.945-45.665-58.2362,210.047-106.29-0.003-26.568000000
Other Information:
Effect Of Forex Changes On Cash -4.063-27.68524.73226.05858.534-18.146-16.404-196.9280.0521.6320.443.5000000
Net Change In Cash 1,395.331856.653-1,075.219-255.063-183.807752.21-608.714-841.5432,406.544383.70721.049101.189-11.557-11.557-11.55724.90524.90524.905
Cash At End Of Period 2,915.7281,520.397663.7441,738.9631,994.0262,177.8331,425.6232,034.3372,875.88469.33685.629117.33416.14516.14516.14527.70227.70227.702